Luminex Corporation (NASDAQ:LMNX)

Thursday, September 3, 2009 | Web News
The Company is lowering 2009 full year previously updated revenue guidance. FULL YEAR 2009 Guidance Ending December a >Source: Business Wire (August...
Wednesday, June 24, 2009 | Web News
“We are pleased with our performance in the first quarter of 2009. In these unprecedented economic times, the company continued to execute well,&#...
Sunday, February 15, 2009 | Web News
Guidance Report: Full Year Fiscal 2009 Guidance Ending December > Source: Business Wire (February 5, 2009)...
See All Research...

Luminex develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company’s xMAP® system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company’s xMAP® technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.

Web site: http://www.luminexcorp.com

Last updated April 28, 2009


Market Data powered by QuoteMedia. Terms of Use